echitabplus-icp
Animal productexperimental
Clinical trial activity
3 trials · 12 clinical orgs · 0 marketing orgs
Phase 1
0
Phase 2
3
Phase 3
2
Phase 4
0
Earliest trial started Apr 1, 2011 (NCT01502774)
Timeline
Indications
Mechanism of action
- Unspecified targetImmunity, passive
immunity, passive
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- echitabplus-icp
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT02599480 | Phase 2 | Apr 1, 2016 | European Clinical Research Infrastructure Network, European Commission, European Society of Cardiology, Université catholique de Louvain, University of Athens, University of Brescia, University of Goettingen, University of Lisbon, University of Nantes, University of Oxford, Wroclaw Medical University |
| NCT02934217 | Phase 3 | Mar 1, 2014 | University of Lyon |
| NCT01502774 | Phase 3 | Apr 1, 2011 | University of Lyon |
Showing 3 of 3 trials
Page 1 / 1
Organizations
Research & Development (12)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| University of Lyon | Academic/Hospital | 2 | 2 | 1 | 2011 |
| European Clinical Research Infrastructure Network | Academic/Hospital | 1 | 0 | 1 | 2016 |
| European Commission | Government | 1 | 0 | 1 | 2016 |
| European Society of Cardiology | Academic/Hospital | 1 | 0 | 1 | 2016 |
| Université catholique de Louvain | Academic/Hospital | 1 | 1 | 1 | 2016 |
| University of Athens | Academic/Hospital | 1 | 0 | 1 | 2016 |
| University of Brescia | Academic/Hospital | 1 | 0 | 1 | 2016 |
| University of Goettingen | Academic/Hospital | 1 | 0 | 1 | 2016 |
| University of Lisbon | Academic/Hospital | 1 | 0 | 1 | 2016 |
| University of Nantes | Academic/Hospital | 1 | 0 | 1 | 2016 |
| University of Oxford | Academic/Hospital | 1 | 0 | 1 | 2016 |
| Wroclaw Medical University | Academic/Hospital | 1 | 0 | 1 | 2016 |
12 organizations
Page 1 / 1